Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Meek | M | 59 | 6 years | |
| Jeremy Springhorn | M | 61 | 7 years | |
| Madhavan Balachandran | M | 73 | 7 years | |
| Robert Gut | M | 59 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Thomas | M | 54 | 6 years | |
| Edward Myles | M | 52 | 4 years | |
| Brian Piekos | M | 49 | 5 years | |
| Scott A. Holmes | M | 50 | 4 years | |
| Michael Narachi | M | 64 | 8 years | |
| Gino Santini | M | 67 | 8 years | |
| William Heiden | M | 64 | 8 years | |
| Anthony Casciano | M | - | 4 years | |
| Brian Pereira | M | 65 | 7 years | |
| Amy Sullivan | F | 54 | - | |
| Joseph Vittiglio | M | 52 | 5 years | |
| Barbara H. Deptula | F | 69 | 7 years | |
| John Fallon | M | 76 | 6 years | |
| Robert Blood | M | - | - | |
| Linda S. Lennox | F | 59 | 5 years | |
| Kathryn Carr Payne | F | - | 4 years | |
| David J. Cerveny | M | 57 | - | |
| Joseph Vincent Bonventre | M | 74 | 5 years | |
| Robert Perez | M | 59 | 11 years | |
| Rajiv De Silva | M | 58 | 1 years | |
| Robert Kaper | M | - | - | |
| Ron Zwanziger | M | 70 | 5 years | |
| Julie Krop | M | 57 | 6 years | |
| Edward C. English | M | 57 | 4 years | |
| James Sulat | M | 73 | 6 years | |
| Scott B. Townsend | M | 56 | - | |
| Lesley Russell | M | 63 | 10 years | |
| Aaron Pelta | M | - | - | |
| Elizabeth Bolgiano | F | 62 | 6 years | |
| Mary Trout | F | 56 | 2 years | |
| Gregory Madison | M | 57 | 1 years | |
| Violetta Cotreau | F | 51 | 4 years | |
| Amit Verma | M | - | - | |
| Carol Satler | M | - | - | |
| Jerald Korn | M | 45 | 3 years | |
| Yong Dai | M | 53 | 3 years | |
| Eric Goossens | M | 58 | 3 years | |
| Nicholas Grund | M | 54 | 3 years | |
| E. Scott Toner | M | - | 3 years | |
| Melissa Bradford-Klug | F | - | 2 years | |
| Michael W. Stevenson | M | - | 4 years | |
| Arpad Simon | M | - | 3 years | |
| Carman Alenson | F | 58 | 1 years | |
| Jonas Niaura | M | - | 3 years | |
| Audrey Wu | F | - | - | |
| Nora Dutta | F | - | 1 years | |
| Alka Batycky | M | 54 | - | |
| Kelly Schick | F | 44 | - | |
| Stephen Andre | M | 62 | - | |
| Peter A. Sears | M | 85 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 8 years |
| Francis Cano | M | 79 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 2 years |
| David Arkowitz | M | 62 | 4 years | |
| John Tucker | M | 61 | - | |
| Ronald Ellis | M | 71 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 1 years |
| Louis Brenner | M | 54 | 4 years | |
| Lee F. Allen | M | 72 | 6 years | |
| Ricardo Zayas | M | 65 | 2 years | |
| Gary Zieziula | M | 69 | 1 years | |
| Edward Jordan | M | 55 | - | |
| Mark B. Skaletsky | M | 75 | 6 years | |
| John Barrie Ward | M | 86 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | - |
| Michael Loberg | M | 76 | 12 years | |
| Harald Petry | M | 65 | 5 years | |
| Brian Kelley | M | 62 | 1 years | |
| Alf E. A. Lindberg | M | 85 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 4 years |
| Steven Caffé | M | - | - | |
| Mark Stanton | M | - | - | |
| Christian Meyer | M | 56 | 4 years | |
| Paul Firuta | M | 58 | 2 years | |
| Paul Williams | M | - | - | |
| Todd H. van Horn | M | - | 2 years | |
| Robert M. Brenner | M | 56 | 2 years | |
| Christopher White | M | 62 | 7 years | |
| Steven Zelenkofske | M | 65 | 1 years | |
| Geoffrey Schuyler Crouse | M | 53 | - | |
| Carolyn Rucci | F | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 69 | 86.25% |
| Netherlands | 11 | 13.75% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Scott T. McMillan
- Personal Network
